Precigen: Funding, Investors & Team (Sep 2026)
Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Precigen has raised $109M across 2 funding rounds on record, the most recent an undisclosed round of $79.0M announced in Dec 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Precigen Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Precigen Funding Rounds
Precigen raised $30.0M in an undisclosed round announced in Aug 2024.
4 months later, an undisclosed round of $79.0M was announced in Dec 2024.
Precigen Founders and Leadership Team
No contact details are on record for this team yet.
Precigen Funding Compared to Other Biotechnology Startups
Precigen's latest round of $79.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Precigen in Biotechnology and Germantown
Companies Similar to Precigen
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Precigen Funding FAQs
What does Precigen do?
Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
How much funding has Precigen raised?
Precigen has raised $109M across 2 rounds on record. The most recent is an undisclosed round of $79.0M announced in Dec 2024.
When did Precigen last raise funding?
Precigen's most recent funding round on record is an undisclosed round of $79.0M, announced in Dec 2024.
Who founded Precigen?
FundedIQ lists Thomas D Reed (Founder), Thomas D. Reed (Founder) at Precigen.
Where is Precigen headquartered?
Precigen is based in Germantown, Maryland, United States.
How many employees does Precigen have?
Precigen is in the 101-250 employee band.
How does Precigen's funding compare to other Biotechnology startups?
Precigen's latest round of $79.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Precigen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Precigen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.